Institutional investors control 2.55% of the outstanding shares in ROSG. This represents a greater percentage of ownership than at almost any other company in the Biotechnology industry. Additionally, during the quarter ended June 2015, these large investors purchased a net $12.5 thousand shares.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
HIGHLANDER CAPITAL MANAGEMENT LL... Bought 36.8 Thousand shares of Rosetta Genomics Ltd